On the morning of June 2, 2020, the 2019 annual general meeting of shareholders of Guizhou Sanli Pharmaceutical Co., Ltd. was held in the conference room of Guizhou Sanli Pharmaceutical Co., Ltd., and a total of 9 shareholders and shareholder representatives participated in the voting on the spot and online, with 293672980 shares representing 72.0984% of the total shares. The meeting was presided over by Chairman Zhang Hai. In addition to Duan Jinghui, an independent director, who failed to attend the meeting due to work reasons, all other directors, supervisors and Secretary of the board of directors attended the meeting, and other senior executives and relevant personnel of the company attended the meeting as nonvoting delegates. Wang Guan and he min of Beijing Guofeng law firm witnessed the meeting.

On the morning of June 2, 2020, the 2019 annual general meeting of shareholders of Guizhou Sanli Pharmaceutical Co., Ltd. was held in the conference room of Guizhou Sanli Pharmaceutical Co., Ltd., and a total of 9 shareholders and shareholder representatives participated in the voting on the spot and online, with 293672980 shares representing 72.0984% of the total shares. The meeting was presided over by Chairman Zhang Hai. In addition to Duan Jinghui, an independent director, who failed to attend the meeting due to work reasons, all other directors, supervisors and Secretary of the board of directors attended the meeting, and other senior executives and relevant personnel of the company attended the meeting as nonvoting delegates. Wang Guan and he min of Beijing Guofeng law firm witnessed the meeting.